Why Chemotherapy That Costs $70,000 in the U.S. Costs $2,500 in IndiaThomas Bollyky
Apr. 14, 2013
Feminists Say It's 'Racist And Sexist' for Italians to Have Italian Babies
WATCH: Did Hillary Clinton Give Hand Signals to Debate Moderator Lester Holt?
Here's A List Of Lester Holt's Incredibly Biased Questions
WATCH: Did Hillary Clinton Have a 'Seizure' During Last Night's Debate?
Online Polls Show Donald Trump Won First Presidential Debate
Why does Gleevec, a leukemia drug that costs $70,000 per year in the United States, cost just $2,500 in India?
It's seemingly simple. Gleevec is under patent in the U.S., but not in India. Accordingly, Novartis, its Swiss-based manufacturer, may prevent competitors from making and selling lower-cost versions of the drug in the U.S., but not in India.